ACP Journal Club. Donepezil or memantine improved cognitive functioning in moderate-to-severe Alzheimer disease
- PMID: 22711111
- DOI: 10.7326/0003-4819-156-12-201206190-02010
ACP Journal Club. Donepezil or memantine improved cognitive functioning in moderate-to-severe Alzheimer disease
Comment on
-
Donepezil and memantine for moderate-to-severe Alzheimer's disease.N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668. N Engl J Med. 2012. PMID: 22397651 Clinical Trial.
Similar articles
-
Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine.Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10. Dement Geriatr Cogn Disord. 2012. PMID: 22572767 Clinical Trial.
-
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):263-8. doi: 10.1097/01.wad.0000213859.35355.59. Alzheimer Dis Assoc Disord. 2006. PMID: 17132971 Clinical Trial.
-
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62. doi: 10.1097/01.wad.0000213860.35355.d4. Alzheimer Dis Assoc Disord. 2006. PMID: 17132970 Clinical Trial.
-
Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease.Postgrad Med. 2012 Nov;124(6):110-6. doi: 10.3810/pgm.2012.11.2589. Postgrad Med. 2012. PMID: 23322144 Review.
-
Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):23-9. doi: 10.1097/01.wad.0000201847.29836.a5. Alzheimer Dis Assoc Disord. 2006. PMID: 16493232 Review.
Cited by
-
Memantine for dementia.Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD003154. doi: 10.1002/14651858.CD003154.pub6. Cochrane Database Syst Rev. 2019. PMID: 30891742 Free PMC article.
-
Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials.Neurol Sci. 2015 Sep;36(9):1633-41. doi: 10.1007/s10072-015-2221-2. Epub 2015 Apr 22. Neurol Sci. 2015. PMID: 25899425
-
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?CNS Neurosci Ther. 2013 Aug;19(8):549-55. doi: 10.1111/cns.12095. Epub 2013 Apr 18. CNS Neurosci Ther. 2013. PMID: 23593992 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources